| Type | Title | Date Released | |
|---|---|---|---|
4 | Lee Chan Henry (Reporting) New | ||
144 | Form 144 | ||
144 | Form 144 | ||
10-Q | Form 10-Q | ||
8-K | BeOne Medicines Announces Q3 2026 Financial Results and Raises Full-Year Guidance | ||
4 | Wang Xiaodong (Reporting) | ||
4 | Wang Xiaodong (Reporting) | ||
4 | Lee Chan Henry (Reporting) | ||
4 | Wang Xiaodong (Reporting) | ||
144 | Form 144 | ||
SCHEDULE 13D/A | BAKER BROS. ADVISORS LP (Filed by) | ||
4 | Wang Xiaodong (Reporting) |
